| Stage | IQV | % of rev | CRL | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $4.4B | 100.00% | $983M | 100.00% | IQV ×4.51 |
| Gross profit | $1.5B | 33.83% | $358M | 36.42% | CRL +2.6pp |
| Operating income | $572M | 12.92% | $203M | 20.62% | CRL +7.7pp |
| Pre-tax income | $386M | 8.72% | $171M | 17.37% | CRL +8.6pp |
| Net income | $352M | 7.95% | $334M | 34.03% | CRL +26.1pp |
| Stage | IQV | CRL | Gap · A − B |
|---|---|---|---|
| Revenue | $4.4B100.00% | $983M100.00% | IQV ×4.51 |
| Gross profit | 33.83%$1.5B | 36.42%$358M | CRL +2.6pp |
| Operating income | 12.92%$572M | 20.62%$203M | CRL +7.7pp |
| Pre-tax income | 8.72%$386M | 17.37%$171M | CRL +8.6pp |
| Net income |
| 7.95%$352M |
| 34.03%$334M |
| CRL +26.1pp |